Preliminary clinical measurement of the expression of B-cell activating factor in Chinese systemic lupus erythematosus patients

Journal of Clinical Laboratory Analysis

Volumn 21, Issue 3, 2007, Pages 183-187

  Lin, Zhou ^a   Yang, Dan Rong ^b   Tu, Xiao Qing ^a   Hao, Wang ^a   Geng, Hong Lian ^a   Kong, Xian Tao ^a   Zhong, Ren Qian ^a   Jiyu, Li ^c  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Autoimmune disorders; B lymphocyte; Enzyme linked immunosorbent assay; Reverse transcript polymerase chain reaction; Systematic lupus erythematosus

Indexed keywords

B CELL ACTIVATING FACTOR; CELL PROTEIN; DOUBLE STRANDED DNA; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CHINESE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; HUMAN; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANTIBODIES, ANTINUCLEAR; ASIAN CONTINENTAL ANCESTRY GROUP; B-CELL ACTIVATING FACTOR; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOGLOBULINS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

MUS;

EID: 34249339766     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20161     Document Type: Article

References (17)

1. Moore PA, Belvedere O, Orr A, et al. BAFF: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 1999;285:260-263.
2. Batten M, Groom J, Cachero TG, et al. BAFF mediates survival of peripheral immature B lymphocyte. J Exp Med 2000; 192:1453-1466.
3. Do RK, Hatada E, Lee H, et al. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J Exp Med 2000;192:953-964.
4. Gross JA, Johnston J, Mudri S, et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 2000;404:995-999.
5. Thompson JS, Bixler SA, Qian F, et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 2001;293:2108-2111.
6. Zhang J, Roschke V, Baker KP, et al. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol 2001;166:6-10.
7. Zhou L, Tu XQ, Zhong R, Kong ZT, et al. [An ELISA method for determination of serum B lymphocyte stimulator levels and its clinical assessment.] Ti Erh Chun i Ta Hsueh Hsueh Pao 2004;25:1317-1319. [Chinese]
8. Zhou L, Fan LY, Wang H, et al. [Establishment of fluorogenic quantitative method for the measurement of the B-lymphocyte stimulator gene expression.] Chung Hua Chien Yen I Hsueh Tsa Chih 2004;27:299-302. [Chinese]
9. Mackay F, Schneider P, Renner P, et al. BAFF and APRIL: a tutorial on B cell survival. Annu Rev Immunol 2003;21:231-264.
10. Mackay F, Mackay CR. The role of BAFF in B-cell maturation, T-cell activation and autoimmunity. Trends Immunol 2002; 23:113-115.
11. Mackay F, Browning JL. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol 2002;2:465-475.
12. Groom J, Kalled SL, Cutler AH, et al. Association of BAFF/ BAFF overexpression on altered B cell differentiation with Sjögren's syndrome. J Clin Invest 2002;109:59-68.
13. Stohl W, Metyas S, Tan SM, et al. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observation. Arthritis Rheum 2003;48: 3475-3486.
14. Szodoray P, Jellestad S, Teague MO, et al. Attenuated apoptosis of B cell activating factor-expressing cells in primary Sjögren's syndrome. Lab Invest 2003;83:357-365.
15. Cheema GS, Roschke V, Hilbert DM, et al. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic disease. Arthritis Rheum 2001;44:1313-1319.
16. Mariette X, Roux S, Zhang J, et al. The level of BAFF correlates with the titres of autoantibodies in human Sjögren's syndrome. Ann Rheum Dis 2003;62:168-171.
17. Collins CE, Gavin AL, Migone TS, et al. B lymphocyte stimulator (BAFF) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BAFF mRNA levels than with plasma BAFF protein levels. Arthritis Res Ther 2006;8:R6.